CD8A and neoplasm: IHC revealed that the YY1 knockdown combined with anti‐PD‐1 treatment group had significantly increased CD8+ T cell infiltration within the tumor, while the GALNT16 overexpression group had reduced CD8+ T cell infiltration (Figure 7G, H).